Prosecution Insights
Last updated: November 20, 2026

Brandon J Fetterolf, USPTO Patent Examiner

Listed by the USPTO as FETTEROLF, BRANDON J

Tech Center 1600 • Art Units: 1622 1626 1628 1629 1642

This examiner grants 51% of resolved cases

Analysis

Fetterolf, Brandon J, works in Tech Center 1600 and Art Unit 1622. The record includes 232 resolved cases, with an allowance rate of 50.9% and a median of 1290 days to allowance. The interview lift is 20.1%, suggesting that interviews may provide useful but limited support during a lengthy prosecution process.

The listed companies are Astrazeneca AB, Novartis AG, and Monash University. The leading firms are Abel Schillinger, LLP, Apex Attorneys at Law, LLP, and Arnall Golden Gregory LLP. Practitioners should combine clear written responses with selective interview use and realistic timing expectations.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

50.9%
Allow Rate
-9.1% vs TC avg
291
Total Applications
+20.1%
Interview Lift
1290
Avg Prosecution Days
Based on 232 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
20.8%
§102 Novelty
28.6%
§103 Obviousness
28.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18729949 SPIROCYCLIC PIPERIDINYL DERIVATIVES AS COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF Non-Final OA Novartis AG
18033724 COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS Non-Final OA MERCK PATENT GMBH
18737447 SUBSTITUTED BENZOFURAN PROPYL AMINE MODULATORS OF MONOAMINERGIC TRANSPORTERS Non-Final OA EmpathBio, Inc.
18857347 FGFR2 INHIBITOR COMPOUNDS Non-Final OA ELI LILLY AND COMPANY
17912272 TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER PBB3 Final Rejection THE GENERAL HOSPITAL CORPORATION
17783455 METHODS OF CONTROLLING OR PREVENTING INFESTATION OF PLANTS BY A PHYTOPATHOGENIC MICROORGANISM OF THE GENUS MACROPHOMINA SPP. Non-Final OA SYNGENTA CROP PROTECTION AG
18030390 NOVEL REDOX-BASED THERAPEUTIC APPROACH FOR TREATMENT OF CANCER Final Rejection THE PENN STATE RESEARCH FOUNDATION
17906138 TREATMENT OF EPILEPSY Final Rejection Katholieke Universiteit Leuven
18853504 COMBINATION THERAPY FOR TREATING CANCER Non-Final OA AstraZeneca AB
18849729 INJECTABLE PREPARATION COMPRISING ISOXAZOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR Non-Final OA LG CHEM, LTD.
18860376 TREATMENT OF NEUROLOGICAL DISORDERS Non-Final OA Praxis Precision Medicines, Inc.
17916904 TOPICAL USE OF ERLOTINIB FOR TREATING KERATODERMAS IN CHILDREN Final Rejection UNIVERSITE PARIS-SACLAY
18014545 THERAPY OF POST-OPERATIVE NAUSEA AND VOMITING Final Rejection LXO US, Inc.
17922890 DOSING METHODS FOR TREATMENT OF CARDIOVASCULAR CONDITIONS Non-Final OA IMBRIA PHARMACEUTICALS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Brandon J Fetterolf's allowance rate?

50.9% of resolved applications examined by Brandon J Fetterolf were allowed (232 resolved cases), compared with 60.5% across Art Unit 1622 over the last five years.

Does an interview help with examiner Brandon J Fetterolf?

This examiner's interview lift is +20.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Brandon J Fetterolf take to allow a patent?

Applications allowed by Brandon J Fetterolf took 1,290 days on average from filing to allowance.

Which art unit does examiner Brandon J Fetterolf work in?

Brandon J Fetterolf examines applications in Art Unit 1622 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month